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ABSTRACT: The role of surface salt bridges in protein stabilization has been a source of controversy. Here
we present the NMR structure of a hyperthermophilic rubredoxin variant (PFRD-XC4) and the
thermodynamic analysis of two surface salt bridges by double mutant cycles. This analysis shows that the
surface side chain to side chain salt bridge between Lys 6 and Glu 49 does not stabilize PFRD-XC4. The
main chain to side chain salt bridge between the N-terminus and Glu 14 was, however, found to stabilize
PFRD-XC4 by 1.5 kcal mol-1. The entropic cost of making a surface salt bridge involving the protein’s
backbone is reduced, since the backbone has already been immobilized upon protein folding.
Proteins from thermophilic organisms offer good model
systems with which to address the origins of thermostability.
Several trends were found to be associated with increased
thermal stability. These trends include increased packing
density, increased core hydrophobicity, decreased length of
surface loops, and improved secondary structure stabilization
such as N-terminal and C-terminal helix capping (1).
Comparison of many thermophilic proteins also indicates a
high level of occurrence of surface electrostatic interactions
relative to mesophilic homologues (1-6). Buried salt bridges
and salt bridges at dimer interfaces as well as surface salt
bridges have been reported to contribute to the increased
stability of proteins (7-11). These findings appear to
contradict other thermodynamic evidence which shows that
surface ion pairs make little contribution to protein stability
(12-14).
It has been difficult to study hyperthermophilic proteins
by thermodynamic analysis, since most of the known
hyperthermophilic proteins do not unfold reversibly (15-
23). We previously designed a Pyroccocus furiosus rubre-
doxin variant (PFRD-XC4)1 to eliminate the iron-binding site
using a computational design algorithm. The iron-binding
site in wild-type rubredoxin is thought to be the cause of its
irreversible unfolding (22). The mutations for PFRD-XC4
are C5L, C8T, C38A, and C41T. PFRD-XC4 is able to fold
in the absence of iron, undergoes reversible denaturation,
and has a melting temperature of 82 °C (24). The variant
provides an excellent opportunity for systematic exploration
of the factors determining protein thermostability.
The NMR solution structure of PFRD-XC4 reveals a fold
similar to that of wild-type P. furiosus rubredoxin (PFRD).
Given that PFRD-XC4 adopts a fold similar to that of PFRD
and undergoes reversible unfolding, the importance of
interactions that are responsible for the extreme stability of
PFRD can now be addressed. Two interactions found in
PFRD, but not in mesophilic rubredoxins, have been
proposed to contribute to its hyperthermostability (5, 25).
These are the salt bridges between the N-terminus and the
side chain of Glu 14 and between the side chains of Lys 6
and Glu 49. Here we present the NMR solution structure of
PFRD-XC4 and thermodynamic analysis of the two salt
bridges by double mutant cycles.
MATERIALS AND METHODS
Mutagenesis and Protein Purification. The hyperthermo-
philic variant PFRD-XC4 and all PFRD-XC4 mutants were
constructed by inverse PCR (26) using a synthetic P. furiosus
rubredoxin gene in plasmid pt7-7 (27). The mutations for
PFRD-XC4 are C5L, C8T, C38A, and C41T. All mutants
were verified by sequencing. Recombinant proteins were
expressed by IPTG induction in BL21(DE3) hosts (Invitro-
gen) as described previously (28) and isolated using a
freeze-thaw method (29). Purification was accomplished by
reverse-phase high-performance liquid chromatography using
first a linear 1%/min followed by a 0.07%/min acetonitrile/
water gradient containing 0.1% TFA. Molecular weights
were verified by mass spectrometry.
NMR Structure Determination. NMR data were collected
on a Varian Unity Plus 600 MHz spectrometer equipped with
a Nalorac inverse probe with a self-shielded z-gradient. NMR
samples were prepared in 90/10 H2O/D2O or 99.9% D2O
with 200 mM NaCl and 25 mM sodium acetate-d3 (pH 6.3).
The sample concentration was approximately 1.5 mM.
Sequential assignment of resonances was achieved by
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standard homonuclear methods (30). Two-dimensional DQF-
COSY (31), TOCSY (32), and NOESY (33) spectra were
acquired at 25 °C. The TOCSY spectrum was recorded with
an 80 ms mixing time using a clean-MLEV17 mixing
sequence. NOESY spectra were acquired with a 150 ms
mixing time for use during resonance assignments and a 100
ms mixing time to derive distance restraints. Water suppres-
sion was accomplished either with presaturation during the
relaxation delay or with pulsed field gradients (34). Spectra
were processed with VNMR (Varian Associates) and were
assigned with ANSIG (35). NOEs were classified into three
distance-bound ranges based on cross-peak intensity: strong
(1.8-2.7 Å), medium (1.8-3.3 Å), and weak (1.8-5.0 Å).
Upper bounds for restraints involving methyl protons were
increased by 0.5 Å to account for the increased intensity of
methyl resonances. Partially overlapped NOEs were set to
weak restraints. Hydrogen bonds were defined on the basis
of the presence of supporting NOE peaks and by association
with slowly exchanging backbone amide protons (protection
factors g 100). Distance restraints for the hydrogen bonds
were as follows: rNH-O ) 1.5-2.8 Å and rN-O ) 2.4-3.5
Å. Dihedral restraints were defined on the basis of the
coupling constants. Residues with a 3JHNHA e 4 Hz had the
 torsional angle restricted to be within the interval of -80°
to -40°. Residues with a 3JHNHA g 8 Hz had the  torsion
angle restricted to be within the interval of -160° to -80°.
3JHNHA values were derived from NOESY cross-peak fine
structure using the INFIT module of XEASY (36).
Structure calculations were performed with X-PLOR (37)
with the use of standard protocols for hybrid distance
geometry-simulated annealing (38-40). Forty structures were
generated and, following regularization and refinement,
resulted in an ensemble of 28 structures with no restraint
violations of >0.3 Å, rms deviations from idealized bond
lengths of <0.004 Å, and rms deviations from idealized bond
angles and impropers of <0.65°.
CD Analysis. CD data were collected on an Aviv 62DS
spectrometer equipped with a thermoelectric unit and using
a 1 cm path length cell. Protein samples were at a concentra-
tion of 5 íM in 50 mM sodium phosphate buffer at pH 6.3.
Concentrations were determined by UV spectrophotometry.
Thermal melts were monitored at 225 nm. Data were
collected every 2 °C with an equilibration time of 2 min
and an averaging time of 10 s. Tm was determined by fitting
the melting curves to a two-state model as described
previously (41). Guanidinium chloride and urea denaturations
were performed at 1 °C. ¢G values, m values, and error
estimates were obtained by fitting the denaturation data to a
two-state transition as described previously (42). GdmCl and
urea concentrations were measured by refractometry.
RESULTS AND DISCUSSION
Structure Determination of PFRD-XC4. To ensure that the
elimination of the iron center did not change the tertiary fold
of PFRD, we determined the solution structure of PFRD-
XC4 by standard two-dimensional 1H NMR methods (30-
33). The structure of PFRD-XC4 was determined from 494
experimental restraints (8.3 restraints per residue) that were
nonredundant with covalent structure, including 452 NOE
distance restraints, 22 dihedral angle restraints, and 20
hydrogen bond restraints (Table 1). Structure calculations
were performed using X-PLOR (37) and standard protocols
for hybrid distance geometry-simulated annealing (38-40).
An ensemble of 28 structures converged with good covalent
geometry and no distance restraint violations of >0.3 Å. The
data reveal a well-ordered structure except for residues 37-
46 with a root-mean-square (rms) deviation from the mean
of 0.52 Å for the backbone of residues 1-36 and 47-51.
Figure 1a shows the superposition of 28 simulated annealing
structures generated using X-PLOR. Residues 37-46 form
a loop that is the least ordered region of the structure. In
PFRD, the metal binding site is between the two loops
formed by residues 5-10 and 37-46, each of which donates
two cysteine residues to tetrahedrally coordinate the iron
atom (Figure 2). The iron covalently links these two loops
and prevents loop mobility. In the PFRD-XC4 structure, one
of these loops (residues 37-46) lacks NOE distance restraints
and is probably present in multiple conformations.
The stereochemical quality of the ensemble of structures
was examined with PROCHECK (43). Apart from the
glycine residues, 64.2% of the residues are in the most
favored regions of  and ª space, 32.1% in the additional
allowed regions, 3.3% in the generously allowed regions,
and 0.4% in the disallowed regions. The average backbone
structure of PFRD-XC4 superimposes onto PFRD’s crystal-
lographic backbone with an rms deviation of 1.2 Å for the
backbone of residues 1-36 and 47-51 (Figure 1b).
Stability Studies of PFRD-XC4 Mutants. The salt bridges
of interest (between residues 1 and 14 and 6 and 49) are in
the well-ordered part of the PFRD-XC4 structure and most
likely adopt conformations similar to those in PFRD (Figure
2). A series of mutants were designed to disrupt these salt
bridges. The resulting proteins were characterized by both
thermal and chemical denaturation (Table 2).
The amino terminus of PFRD makes a main chain to side
chain salt bridge with Glu 14. We used double mutant cycles
Table 1: NMR Structure Statistics
No. of Distance Restraints
intraresidue 162
sequential 96
short-range (ji - jj ) 2-5 residues) 80





rms deviation 〈SA〉a ( SDb (SA)rd
distance restraint (Å) 0.031 ( 0.003 0.019
idealized geometry
bonds (Å) 0.0039 ( 0.0002 0.0019
angles (deg) 0.64 ( 0.02 0.52
impropers (deg) 0.44 ( 0.02 0.37
Structural Statistics
atomic rms deviation (Å) 〈SA〉 vs SAc ( SD
backbone (residues 1-51) 1.02 ( 0.05
heavy atoms (residues 1-51) 1.42 ( 0.04
backbone (residues 1-36 and 47-51) 0.52 ( 0.02
heavy atoms (residues 1-36 and 47-51) 0.97 ( 0.03
atomic rms deviations between PFRD
and PFRD-XC4 backbone
(residues 1-36 and 47-51)
1.18
a 〈SA〉 are 28 simulated annealing structures. b SD is the standard
deviation. c SA is the average structure. d (SA)r is the minimized average
structure.
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to isolate the stabilization effect of this interaction (8, 9).
The strength of interaction, ¢GXYinteraction, is calculated
according to eq 1, where ¢GXY, ¢GXA, ¢GAY, and ¢GAA
are the free energies of unfolding for the unmutated protein,
the two singly mutated proteins, and the doubly mutated
protein, respectively.
In mesophilic rubredoxins, methionine is retained at the
N-terminus in contrast to the thermophile. The extended
N-terminus is too far from the side chain of Glu 14 to form
a salt bridge. To extend the N-terminus of the hyperther-
mophilic variant PFRD-XC4, residue 1 was mutated to a
large amino acid (Gln), resulting in the retention of the
N-terminal methionine. Mutants 14Q and 1Q14Q were also
prepared to complete the double mutant cycle. Gln was
selected at position 14 to disrupt any ionic interaction with
the N-terminus while preserving the potential hydrogen bond
to the N-terminus. Mutants 1Q, 14Q, and 1Q14Q were folded
at room temperature, with Tm values reduced by 20-40 °C
relative to that of PFRD-XC4 (Table 2).
Guanidinium chloride (GdmCl) chemical denaturations
yielded the following free energies of unfolding: ¢Gu(PFRD-
XC4) ) 3.2 kcal mol-1, ¢Gu(1Q) ) 2.1 kcal mol-1, ¢Gu-
(14Q) ) 1.7 kcal mol-1, and ¢Gu(1Q14Q) ) 1.5 kcal mol-1
(Figure 3a). Due to the lack of well-defined pretransition
baselines in the guanidinium chloride denaturation curves
for mutants 14Q and 1Q14Q, the denaturation data were fit
to a two-state model with a fixed pretransition slope. The
pretransition slope was determined by averaging the pre-
transition slopes from seven separate PFRD-XC4 mutants.
Little variation in the pretransition slopes was found among
the seven PFRD-XC4 mutants, resulting in a0.1 kcal mol-1
error in the final fit of 14Q and 1Q14Q. On the basis of the
guanidinium chloride-derived ¢Gu values of PFRD-XC4, 1Q,
14Q, and 1Q14Q (Table 2), the ionic component of the salt
bridge between the N-terminus and Glu 14 stabilizes PFRD-
XC4 by 0.9 kcal mol-1 (Table 3).
Urea denaturations yielded the following free energies of
unfolding: ¢Gu(PFRD-XC4) ) 4.6 kcal mol-1, ¢Gu(1Q)
FIGURE 1: Stereoview of the PFRD-XC4 structure ensemble and comparison to the PFRD X-ray structure. (a) Best fit superposition of 28
simulated annealing structures. (b) Structural comparison of the PFRD (red) and PFRD-XC4 (blue) backbones. The region of greatest
deviation is the minimally restrained loop of residues 37-45. Structure figures were generated using MOLMOL (50).
¢GXYinteraction ) (¢GXY - ¢GAA) -
[(¢GXA - ¢GAA) + (¢GAY - ¢GAA)] (1)
FIGURE 2: Ribbon diagram of wild-type P. furiosus rubredoxin
showing the two salt bridges and the four cysteine residues that
coordinate the iron.
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) 3.5 kcal mol-1, ¢Gu(14Q) ) 2.7 kcal mol-1, and ¢Gu-
(1Q14Q) ) 2.1 kcal mol-1 (Table 2). The urea denaturation
data suggest that the ionic component of the N-terminal salt
bridge stabilizes PFRD-XC4 by 0.5 kcal mol-1 (Table 3).
Mutants 14T and 1Q14T were designed to eliminate both
the ionic and hydrogen bond components of the salt bridge
between the N-terminus and Glu 14. GdmCl denaturations
were not possible due to the low stability of these mutants.
Urea denaturations yielded the following free energies of
unfolding: ¢Gu(14T) ) 1.3 kcal mol-1 and ¢Gu(1Q14TQ)
) 1.7 kcal mol-1 (Figure 3b). On the basis of the urea
denaturation data, the N-terminal salt bridge between the
N-terminus and Glu 14 stabilizes PFRD-XC4 by 1.5 kcal
mol-1.
The second salt bridge of interest in PFRD is formed by
the side chains of Lys 6 and Glu 49. Mutants 6A, 49A, and
6A49A were created to disrupt this interaction. 6A, 49A,
and 6A49A have melting temperatures lowered by only 5-9
°C relative to that of PFRD-XC4. The guanidinium chloride
denaturation data (Table 2) do not show significant thermo-
dynamic destabilization relative to PFRD-XC4: ¢Gu(PFRD-
XC4) ) 3.2 kcal mol-1, ¢Gu(6A) ) 3.2 kcal mol-1,
¢Gu(49A) ) 3.1 kcal mol-1, and ¢Gu(6A49A) ) 2.8 kcal
mol-1. The experimentally obtained ¢Ginteraction for this salt
bridge is -0.3 kcal mol-1 (Table 3). These data suggest that
the side chain to side chain salt bridge between Lys 6 and
Glu 49 in rubredoxin might be slightly destabilizing.
Urea denaturation data yield the following values: ¢Gu-
(PFRD-XC4) ) 4.6 kcal mol-1, ¢Gu(6A) ) 4.0 kcal mol-1,
¢Gu(49A) ) 4.1 kcal mol-1, and ¢Gu(6A49A) ) 3.8 kcal
mol-1 (Figure 3b). The urea denaturation data suggest that
the salt bridge between Lys 6 and Glu 49 slightly stabilizes
PFRD-XC4 by 0.3 kcal mol-1. Taken together, the chemical
and thermal denaturation data suggest that salt bridge
between Lys 6 and Glu 49 has little effect on the stability of
PFRD-XC4.
CONCLUSIONS
Theoretical and some experimental results suggest that
forming a solvent-exposed ion pair may not be favorable,
because in the process two ions have to be desolvated and
immobilized (9, 12, 14, 44-47). The surface salt bridge
















PFRD-XC4 82 3.2 1.68 1.9 4.6 5.7 0.81
PFRD-XC4-1Q 63 2.1 0.91 2.3 3.5 3.8 0.93
PFRD-XC4-14Q 57 1.7 0.63 2.5 2.7 3.0 0.91
PFRD-XC4-1Q14Q 39 1.5 0.50 3.0 2.1 2.0 1.03
PFRD-XC4-14T 38 - - - 1.3 1.3 0.98
PFRD-XC4-1Q14T 41 - - - 1.7 1.6 1.03
PFRD-XC4-6A 74 3.2 1.60 2.0 4.0 4.9 0.81
PFRD-XC4-49A 77 3.1 1.35 2.3 4.1 4.8 0.86
PFRD-XC4-6A49A 74 2.8 1.27 2.2 3.8 4.5 0.84
a Midpoint of thermal unfolding transition determined by CD. b Free energy of unfolding at 1 °C determined by GdmCl denaturations. c Midpoint
of the GdmCl unfolding transition. d Slope of ¢G vs GdmCl concentration. e Free energy of unfolding at 1 °C determined by urea denaturations.
f Midpoint of the urea unfolding transition. g Slope of ¢G vs urea concentration.
FIGURE 3: Chemical denaturation curves for PFRD-XC4 (O), 1Q
(]), 14Q ([), 1Q14Q (4), 14T (+), 1Q14T (2), 6A (9), 49A
(b), and 6A49A (0) at 1 °C in (a) guanidinium chloride and (b)
urea (to have the curves appear on the same plot, the initial and
final points were arbitrarily called 0 and 100% unfolded despite
the fact that proteins 14Q, 14T, 1Q14Q, and 1Q14T probably have
an unfolded population even at 0% denaturant).







GdmCl 0.9 - -0.3
urea 0.5 1.5 0.3
average 0.7 1.5 0.0
a Ionic component of the interaction between the N-terminus and
the side chain of residue 14. b Total salt bridge interaction between
the N-terminus and the side chain of residue 14. c Total salt bridge
interaction between side chains of residues 6 and 49.
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between the side chains of Lys 6 and Glu 49, in which both
side chains are immobilized, does not contribute to the overall
stability of PFRD-XC4 at 1 °C and thus supports these
findings. This salt bridge might play a role in setting the
â-sheet register of rubredoxin or might be more stabilizing
at higher temperatures (48). Previous reports have suggested
that forming a salt bridge network might be stabilizing (2-
4, 21, 47, 49). In ion pair network formation after the first
two residues are desolvated and immobilized, only one
additional side chain needs to be desolvated and immobilized
upon salt bridge formation, lowering the energetic cost.
Forming a main chain to side chain salt bridge between the
N-terminus and the side chain of Glu 14 in PFRD-XC4
stabilizes PFRD-XC4 by 1.5 kcal mol-1. Main chain to side
chain ion pairs may also have a lower formation cost, because
the main chain is already fixed and only one additional
residue must be immobilized. In PFRD-XC4, the N-terminus
participates in the â-sheet and is immobilized. The main
chain in PFRD-XC4 has already paid the immobilization
entropy cost upon protein folding; thus, the energetic cost
of forming a salt bridge to the N-terminus is significantly
reduced in a manner similar to salt bridge formation in a
surface ion pair network.
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